nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—Atomoxetine—SLC6A4—conduct disorder	0.00351	0.565	CrCbGaD
Phenoxybenzamine—Atomoxetine—HTR2A—conduct disorder	0.00269	0.434	CrCbGaD
Phenoxybenzamine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00262	0.00264	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00252	0.00254	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR ligand binding—CGA—conduct disorder	0.00252	0.00254	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00251	0.00252	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00244	0.00246	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00241	0.00243	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—MB21D1—conduct disorder	0.0024	0.00242	CbGpPWpGaD
Phenoxybenzamine—CALM3—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.00239	0.0024	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00239	0.0024	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—G alpha (i) signalling events—DRD4—conduct disorder	0.00233	0.00235	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00233	0.00234	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—MB21D1—conduct disorder	0.00232	0.00234	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—MB21D1—conduct disorder	0.00232	0.00234	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00232	0.00233	CbGpPWpGaD
Phenoxybenzamine—CALM2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.00231	0.00232	CbGpPWpGaD
Phenoxybenzamine—CALM1—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.00231	0.00232	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00228	0.0023	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00225	0.00226	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—G alpha (q) signalling events—HTR2A—conduct disorder	0.00221	0.00223	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00216	0.00218	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00216	0.00217	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR downstream signaling—CGA—conduct disorder	0.00208	0.00209	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Neuronal System—COMT—conduct disorder	0.00207	0.00209	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00206	0.00207	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR ligand binding—DRD4—conduct disorder	0.00206	0.00207	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Neuronal System—MAOA—conduct disorder	0.00206	0.00207	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.002	0.00201	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00198	0.00199	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.00197	0.00198	CbGpPWpGaD
Phenoxybenzamine—CALM3—Transmission across Chemical Synapses—COMT—conduct disorder	0.00195	0.00196	CbGpPWpGaD
Phenoxybenzamine—CALM3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00194	0.00195	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Neuronal System—COMT—conduct disorder	0.00193	0.00195	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00192	0.00193	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Neuronal System—MAOA—conduct disorder	0.00192	0.00193	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—CGA—conduct disorder	0.00189	0.0019	CbGpPWpGaD
Phenoxybenzamine—CALM2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00189	0.0019	CbGpPWpGaD
Phenoxybenzamine—CALM1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00189	0.0019	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—CGA—conduct disorder	0.00188	0.00189	CbGpPWpGaD
Phenoxybenzamine—CALM2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00187	0.00189	CbGpPWpGaD
Phenoxybenzamine—CALM1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00187	0.00189	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00186	0.00187	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR ligand binding—DRD4—conduct disorder	0.00186	0.00187	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00185	0.00187	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—CGA—conduct disorder	0.00185	0.00187	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—CGA—conduct disorder	0.00185	0.00186	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00184	0.00185	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR ligand binding—DRD4—conduct disorder	0.00184	0.00185	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00177	0.00178	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—POLR3A—conduct disorder	0.00176	0.00177	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00176	0.00177	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—CGA—conduct disorder	0.00175	0.00177	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00174	0.00175	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR ligand binding—DRD4—conduct disorder	0.00174	0.00175	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	0.00173	0.00174	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00171	0.00172	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.00171	0.00172	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—POLR3A—conduct disorder	0.00171	0.00172	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—POLR3A—conduct disorder	0.00171	0.00172	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—CGA—conduct disorder	0.00171	0.00172	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—CGA—conduct disorder	0.00168	0.00169	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00159	0.0016	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—CGA—conduct disorder	0.00159	0.0016	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00157	0.00158	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—CGA—conduct disorder	0.00157	0.00158	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.00153	0.00154	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00152	0.00153	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.00152	0.00153	CbGpPWpGaD
Phenoxybenzamine—CALM3—Neuronal System—COMT—conduct disorder	0.0015	0.0015	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00149	0.0015	CbGpPWpGaD
Phenoxybenzamine—CALM3—Neuronal System—MAOA—conduct disorder	0.00148	0.00149	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—WASF1—conduct disorder	0.00148	0.00149	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00147	0.00148	CbGpPWpGaD
Phenoxybenzamine—CALM2—Neuronal System—COMT—conduct disorder	0.00145	0.00146	CbGpPWpGaD
Phenoxybenzamine—CALM1—Neuronal System—COMT—conduct disorder	0.00145	0.00146	CbGpPWpGaD
Phenoxybenzamine—CALM1—Neuronal System—MAOA—conduct disorder	0.00144	0.00145	CbGpPWpGaD
Phenoxybenzamine—CALM2—Neuronal System—MAOA—conduct disorder	0.00144	0.00145	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—WASF1—conduct disorder	0.00144	0.00145	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—WASF1—conduct disorder	0.00144	0.00145	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	0.00143	0.00143	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00141	0.00142	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	0.00141	0.00142	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—MB21D1—conduct disorder	0.0014	0.00141	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.00139	0.0014	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—MB21D1—conduct disorder	0.00135	0.00136	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—MB21D1—conduct disorder	0.00135	0.00136	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	0.00135	0.00135	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.0013	0.00131	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—CGA—conduct disorder	0.00129	0.0013	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	0.00121	0.00122	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00121	0.00122	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR ligand binding—HTR2A—conduct disorder	0.0012	0.00121	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—CGA—conduct disorder	0.00118	0.00119	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	0.00117	0.00117	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—CGA—conduct disorder	0.00116	0.00116	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—CGA—conduct disorder	0.00114	0.00115	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—CGA—conduct disorder	0.00114	0.00115	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	0.00113	0.00114	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—CGA—conduct disorder	0.00113	0.00113	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	0.00112	0.00112	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CGA—conduct disorder	0.00112	0.00112	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—CGA—conduct disorder	0.00108	0.00109	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	0.00106	0.00106	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	0.00105	0.00106	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—DRD4—conduct disorder	0.00104	0.00104	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00103	0.00103	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—POLR3A—conduct disorder	0.00103	0.00103	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00102	0.00103	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00101	0.00102	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CGA—conduct disorder	0.00101	0.00101	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CGA—conduct disorder	0.000995	0.001	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—POLR3A—conduct disorder	0.000994	0.001	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—POLR3A—conduct disorder	0.000994	0.001	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	0.000992	0.000998	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	0.000983	0.000989	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	0.000967	0.000973	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	0.000955	0.000961	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—DRD4—conduct disorder	0.000943	0.000949	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CGA—conduct disorder	0.000941	0.000947	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CGA—conduct disorder	0.000926	0.000932	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	0.000921	0.000927	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—CGA—conduct disorder	0.000914	0.00092	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—WASF1—conduct disorder	0.000894	0.0009	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	0.000892	0.000898	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	0.000878	0.000884	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—WASF1—conduct disorder	0.000865	0.00087	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	0.000859	0.000864	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—WASF1—conduct disorder	0.000836	0.000842	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—WASF1—conduct disorder	0.000836	0.000842	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—CGA—conduct disorder	0.000834	0.000839	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—COMT—conduct disorder	0.000833	0.000838	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—MAOA—conduct disorder	0.000827	0.000832	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CGA—conduct disorder	0.000823	0.000828	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—WASF1—conduct disorder	0.000808	0.000813	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—CGA—conduct disorder	0.000807	0.000812	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—CGA—conduct disorder	0.000807	0.000812	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	0.000798	0.000803	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—WASF1—conduct disorder	0.000797	0.000802	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	0.00078	0.000785	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CGA—conduct disorder	0.000764	0.000769	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	0.00076	0.000765	CbGpPWpGaD
Phenoxybenzamine—CALM3—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	0.000756	0.000761	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—WASF1—conduct disorder	0.000754	0.000759	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—WASF1—conduct disorder	0.000742	0.000747	CbGpPWpGaD
Phenoxybenzamine—CALM1—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	0.000732	0.000736	CbGpPWpGaD
Phenoxybenzamine—CALM2—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	0.000732	0.000736	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	0.000725	0.000729	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by WNT in cancer—EP300—conduct disorder	0.000702	0.000707	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CGA—conduct disorder	0.000698	0.000702	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	0.00069	0.000695	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	0.000686	0.000691	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by WNT in cancer—EP300—conduct disorder	0.000679	0.000684	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by WNT in cancer—EP300—conduct disorder	0.000679	0.000684	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—HTR2A—conduct disorder	0.000678	0.000682	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CGA—conduct disorder	0.000675	0.000679	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CGA—conduct disorder	0.000675	0.000679	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—DRD4—conduct disorder	0.000661	0.000665	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	0.000659	0.000664	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	0.000641	0.000645	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—DRD4—conduct disorder	0.00064	0.000644	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—DRD4—conduct disorder	0.00064	0.000644	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	0.000631	0.000635	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—DRD4—conduct disorder	0.000625	0.000629	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	0.000623	0.000627	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—HTR2A—conduct disorder	0.000615	0.000619	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—WASF1—conduct disorder	0.000613	0.000617	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	0.000582	0.000586	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by Wnt—EP300—conduct disorder	0.000579	0.000583	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Hemostasis—EP300—conduct disorder	0.000575	0.000579	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	0.000573	0.000577	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—DRD4—conduct disorder	0.000564	0.000568	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	0.00056	0.000564	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by Wnt—EP300—conduct disorder	0.00056	0.000564	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by Wnt—EP300—conduct disorder	0.00056	0.000564	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—WASF1—conduct disorder	0.000559	0.000563	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—DRD4—conduct disorder	0.000557	0.000561	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—WASF1—conduct disorder	0.000541	0.000544	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—WASF1—conduct disorder	0.000541	0.000544	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—EP300—conduct disorder	0.000537	0.000541	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—DRD4—conduct disorder	0.000527	0.00053	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—COMT—conduct disorder	0.000522	0.000526	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	0.000521	0.000524	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—DRD4—conduct disorder	0.000519	0.000522	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—MAOA—conduct disorder	0.000519	0.000522	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	0.000509	0.000512	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—COMT—conduct disorder	0.000508	0.000511	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—MAOA—conduct disorder	0.000505	0.000508	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—COMT—conduct disorder	0.000487	0.00049	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—MAOA—conduct disorder	0.000483	0.000486	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	0.000473	0.000476	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	0.000461	0.000464	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—EP300—conduct disorder	0.000437	0.000439	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—HTR2A—conduct disorder	0.000431	0.000434	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—DRD4—conduct disorder	0.000428	0.000431	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—HTR2A—conduct disorder	0.000417	0.00042	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—HTR2A—conduct disorder	0.000417	0.00042	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—COMT—conduct disorder	0.000413	0.000415	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—MAOA—conduct disorder	0.00041	0.000412	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	0.000408	0.00041	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—EP300—conduct disorder	0.000398	0.000401	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—DRD4—conduct disorder	0.000391	0.000393	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CGA—conduct disorder	0.00039	0.000392	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—EP300—conduct disorder	0.000385	0.000388	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—EP300—conduct disorder	0.000385	0.000388	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—DRD4—conduct disorder	0.000378	0.00038	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—DRD4—conduct disorder	0.000378	0.00038	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—COMT—conduct disorder	0.000377	0.000379	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—MAOA—conduct disorder	0.000374	0.000376	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	0.000368	0.00037	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—COMT—conduct disorder	0.000364	0.000367	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—COMT—conduct disorder	0.000364	0.000367	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—HTR2A—conduct disorder	0.000363	0.000366	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—MAOA—conduct disorder	0.000362	0.000364	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—MAOA—conduct disorder	0.000362	0.000364	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—EP300—conduct disorder	0.000359	0.000361	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—EP300—conduct disorder	0.000357	0.000359	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—EP300—conduct disorder	0.000347	0.000349	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—EP300—conduct disorder	0.000347	0.000349	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	0.000344	0.000346	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	0.000338	0.000341	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	0.000301	0.000303	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	0.000279	0.000281	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—HTR2A—conduct disorder	0.000255	0.000256	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—HTR2A—conduct disorder	0.000247	0.000248	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—HTR2A—conduct disorder	0.000247	0.000248	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—EP300—conduct disorder	0.000224	0.000225	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—EP300—conduct disorder	0.000218	0.000219	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—EP300—conduct disorder	0.000216	0.000217	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—EP300—conduct disorder	0.000209	0.00021	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—EP300—conduct disorder	0.000209	0.00021	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—EP300—conduct disorder	0.000202	0.000203	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—EP300—conduct disorder	0.000202	0.000203	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—EP300—conduct disorder	0.000195	0.000196	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—EP300—conduct disorder	0.000193	0.000194	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—EP300—conduct disorder	0.000193	0.000194	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—EP300—conduct disorder	0.000187	0.000188	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—EP300—conduct disorder	0.000187	0.000188	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—EP300—conduct disorder	0.000182	0.000183	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—EP300—conduct disorder	0.000179	0.00018	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—EP300—conduct disorder	0.000177	0.000178	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—COMT—conduct disorder	0.000176	0.000177	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—MAOA—conduct disorder	0.000175	0.000176	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—EP300—conduct disorder	0.000161	0.000162	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—EP300—conduct disorder	0.000159	0.00016	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—EP300—conduct disorder	0.000156	0.000157	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—EP300—conduct disorder	0.000156	0.000157	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—EP300—conduct disorder	0.000148	0.000149	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—EP300—conduct disorder	0.000135	0.000136	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—EP300—conduct disorder	0.000131	0.000131	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—EP300—conduct disorder	0.000131	0.000131	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—EP300—conduct disorder	7.54e-05	7.59e-05	CbGpPWpGaD
